US Cannabis MSOs Poised for Windfall Following Schedule III Reclassification

The US cannabis industry has reached a pivotal milestone as the government moves to reclassify medical marijuana products from Schedule I to Schedule III, with recreational products expected to follow. This shift represents a significant regulatory victory for multi-state operators (MSOs), primarily by alleviating the tax burdens associated with Section 280E of the tax code. By moving to Schedule III, cannabis companies can now claim a broader range of business expenses on their tax returns. This change is expected to directly improve the bottom line for the largest players in the space, providing them with the capital necessary to scale operations in a highly competitive and fragmented market. Curaleaf Holdings (CURLF) stands as a primary beneficiary, with a footprint spanning 15 states and 159 locations as of late 2025. The company reported nearly $1.3 billion in revenue last year and estimates that rescheduling could have saved it approximately $116 million in taxes for the 2025 fiscal year. Its shares have already reacted positively, rising 34% year-to-date. Green Thumb Industries (GTBIF) also shows strong potential, operating 113 stores across 14 states. Already profitable with a net income of $114 million last year on $1.2 billion in revenue, the company's leadership estimates that rescheduling could generate up to $60 million in additional annual free cash flow. Trulieve Cannabis (TCNNF) is similarly positioned to benefit, leveraging its extensive network of 233 retail locations, primarily concentrated in Florida. While the industry has faced growth headwinds, the influx of tax-related liquidity is expected to catalyze a new wave of expansion and operational efficiency across the sector.